Scientists have discovered Ozempic Rival Potenti that could help people lose weight with less nausea

Wegovy, eat the heart out. In a new search card, scientists that discovered a bone hormone that could help people avoid the secondary effects common

A team of researchers at Stanford Medicine carried out the study, Posted Last week in the nature of the newspaper. With the help of artificial intelligence, identified a previously unpleasant peptid that seemed in a safe mode and pigs of thumbnails without causing gastrointestine. More studies will be not to check safety and efficiency in people, but discoveries provides a fence to what could be the shadow of the shadows.

The emergency of the semaglitide and the similar drugs in the past few years have been Really revolutionary for the field of obesity medicine. These medications are used for the 2nd diabetes, they demonstrated much more effective to help people lose the weight that’s diet and the results ranging from 15% to 20% Weight lost in clinical trials. Semaglutides works out glp-1, a hormone that helps our appella and metabolism, between other medicines as mimp-1 and other hormones.

As terrobreak as these drugs are known to cause gi-sleeve tracks, and they can rarely cause more severe as gastropinee (stomach paralysis). Scientists also worked to find the most recent generation drugs that can also provide a loss of weight or offer other cycling, as being available as a pill. In that vein, Stanfford Medicine of Medicine changed a roman strategy to find their drug candidate.

Many hormones in the body are activated only when its forersors are included by specific enzymes. These precursors are called of the prohorms, and the family of enzymes that cut are called the prohorms converts. Rate researchers one of these enzymes, convertase prohorms 1/3, which is known to help produce glp-1. They decided to see if they can find other hormones related to the useful hunger of naturally from enzyme. To speed up this job process, have developed a computer algorithm (nicknamed peptida predictor) to restrict the list of potential molecules that fit their criteria.

This screen is located an initial batch of 373 Publici who can give us a few 2,73 can you (perir are the construction vames, but may have their own tight functions in the body). From here, researchers reset 100 peptids that know or suspects may affect his brain crawling (including glp-1 for comparison). And definitely, identified a molecule that seemed to be particularly by promising, a peptide of 12 amino acid called brinp2-relative, or brp.

Scientists tried to the BRP on lab pigs and pigs in thumbnails (MinPigs are designed to people resembling people metabolically). They have found that a single dose of brp very reduced the appetite of the two animals in the short terms, sometimes by 50%. And mice obese from the wispy wispy significantly on a whole two weeks, with most of this weight that has been fat stored.

The further experts to the effects of the License of the License of the brain, do not involve the GLP-1 receiver has not made the animals in commonly with the ocempic drugs. The Dosati Animals did not have changes to their movement, the level of eagerness, or the water engagement, suggest that the brp can be tolerated in a safe mode when drug.

“The receiver intended by Sense? If they were found in the brain, pancreas and other weaving.” Today Senior Senensia sennicate, a bearing pathology to stanford, in a statement by the university. “In contrast, the BRP appears to farm in the hypotalamus, which appetite checks and metabolism.”

Team’s results are, of course preliminary at this point. It will take a lot of more time and research, including the clinical properties in man, before the bRTs should see like the next next thing in obesity treatment. But the squad’s discovery is the last to suggest that semagluities really shot a change in the sea in obesity treatment. There are now do you do experience experimental drugs in pipeline that threaten or even exceeds ozempic / wegovy, including Different formulations of semaglitide. For their part, SVVson and his colleagues are already threaded on the brpis, and she has been founded a company that she will hide a molecule for clinical use.

No drugs don’t come without side effects, but the future of obesity treatment could some day involve a lot less nausea.